Overlap syndrome-associated autoantibodies were mostly detected in both SSc and PM/DM patients, and among them, anti-SS-A/Ro52 antibody had the highest prevalence rate of 25.2% in SSc and 36.0% in PM/DM. This evidence concerns the gene TRIM21 and dermatomyositis.